133 related articles for article (PubMed ID: 7833131)
1. Double modulation of 5-fluorouracil in advanced colorectal cancer with low-dose interferon-alpha 2b and folinic acid. The "GISCAD" experience. Italian Group for the Study of Digestive Tract Cancer.
Labianca R; Giaccon G; Barni S; Ambrosini G; Iirillo A; Fiorentini G; Duro M; Piazza E; Oliani C; Pancera G
Eur J Cancer; 1994; 30A(11):1611-6. PubMed ID: 7833131
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.
Schmoll HJ; Köhne-Wömpner CH; Hiddemann W; Knipp H; Wilke H; Bodenstein H; Schöffski P; Bokemeyer C; Lohrmann HP; Preiss J
Semin Oncol; 1992 Apr; 19(2 Suppl 3):191-6. PubMed ID: 1557646
[TBL] [Abstract][Full Text] [Related]
3. High dose alpha-2b interferon + folinic acid in the modulation of 5-fluorouracil. A phase II study in advanced colorectal cancer with evidence of an unfavourable cost/benefit ratio.
Labianca R; Pancera G; Tedeschi L; Dallavalle G; Luporini A; Luporini G
Tumori; 1992 Feb; 78(1):32-4. PubMed ID: 1609456
[TBL] [Abstract][Full Text] [Related]
4. Fluorouracil plus interferon + folinic acid in regional and systemic therapy in colorectal cancer.
Preiss J
Semin Oncol; 1992 Apr; 19(2 Suppl 3):220-4. PubMed ID: 1557652
[TBL] [Abstract][Full Text] [Related]
5. Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer. First results of a randomized multicenter study by the Association of Medical Oncology of the German Cancer Society (AIO).
Köhne CH; Wilke H; Hecker H; Schöffski P; Käufer C; Rauschecker H; Andreesen R; Ohl U; Lange HJ; Klaassen U
Ann Oncol; 1995 May; 6(5):461-6. PubMed ID: 7669711
[TBL] [Abstract][Full Text] [Related]
6. Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administration.
Steger GG; Mader RM; Djavanmard MP; Gnant MF; Locker G; Marosi C; Rainer H; Jakesz R
J Cancer Res Clin Oncol; 1994; 120(5):314-8. PubMed ID: 8126062
[TBL] [Abstract][Full Text] [Related]
7. Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: results of a phase II trial.
Jäger E; Bernhard H; Klein O; Wächter B; Theiss F; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Ann Oncol; 1995 Feb; 6(2):153-6. PubMed ID: 7540418
[TBL] [Abstract][Full Text] [Related]
8. Retrospective comparative analysis of 5FU + low-dose folinic acid vs. 5FU + high-dose folinic acid in the treatment of metastatic colorectal cancer. The Ottawa experience.
Maroun JA; Cripps C; Goel R; Dahrouge S; Boisvert D
Am J Clin Oncol; 1997 Aug; 20(4):387-92. PubMed ID: 9256896
[TBL] [Abstract][Full Text] [Related]
9. Different dose regimens of 5-fluorouracil and interferon-alpha in patients with metastatic colorectal carcinoma.
Ragnhammar P; Blomgren H; Edler D; Lundell G; Magnusson I; Sonnenfeld T
Eur J Cancer; 1995; 31A(3):315-20. PubMed ID: 7786594
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil and leucovorin with or without interferon alfa-2b in advanced colorectal cancer: analysis of a prospective randomized phase III trial. Hellenic Cooperative Oncology Group.
Kosmidis PA; Tsavaris N; Skarlos D; Theocharis D; Samantas E; Pavlidis N; Briassoulis E; Fountzilas G
J Clin Oncol; 1996 Oct; 14(10):2682-7. PubMed ID: 8874327
[TBL] [Abstract][Full Text] [Related]
11. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Knauf WU; Boese-Landgraf J; Schalhorn A; Zeitz M
Semin Oncol; 1992 Apr; 19(2 Suppl 3):197-203. PubMed ID: 1557647
[TBL] [Abstract][Full Text] [Related]
12. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group.
Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M
Cancer; 1999 Feb; 85(3):535-45. PubMed ID: 10091727
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.
Sobrero A; Nobile MT; Guglielmi A; Mori A; Aschele C; Bolli E; Tixi L; Gallo L; Parodi GC; Bruzzi P
Eur J Cancer; 1992; 28A(4-5):850-2. PubMed ID: 1524906
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil-interferon-alpha 2b adjuvant treatment of Dukes C colorectal cancer.
Frasci G; Leone F; Monaco M; Cremone L; Sapio U; Faiella F; Espinosa A; Persico G
Dis Colon Rectum; 1994 Jul; 37(7):643-50. PubMed ID: 8026229
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.
Recchia F; Nuzzo A; Lalli A; Lombardo M; Di Lullo L; Fabiani F; Fanini R; Venturoni L; Torchio P; Peretti G
Am J Clin Oncol; 1996 Jun; 19(3):301-4. PubMed ID: 8638546
[TBL] [Abstract][Full Text] [Related]
16. Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
Hill M; Norman A; Cunningham D; Findlay M; Nicolson V; Hill A; Iveson A; Evans C; Joffe J; Nicolson M
J Clin Oncol; 1995 Jun; 13(6):1297-302. PubMed ID: 7751874
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinoma.
Pazdur R; Ajani JA; Patt YZ; Winn R; Jackson D; Shepard B; DuBrow R; Campos L; Quaraishi M; Faintuch J
J Clin Oncol; 1990 Dec; 8(12):2027-31. PubMed ID: 2230894
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion of high-dose 5-fluorouracil in combination with leucovorin and recombinant interferon-alpha-2b in patients with advanced colorectal cancer. A Multicenter Phase II study.
Punt CJ; Burghouts JT; Croles JJ; van Liessum PA; de Mulder PH; Kamm Y
Cancer; 1993 Oct; 72(7):2107-11. PubMed ID: 8374869
[TBL] [Abstract][Full Text] [Related]
19. Double 5-fluorouracil modulation with folinic acid and recombinant alpha-2B-interferon. A phase I-II study in metastatic colorectal cancer patients.
Brunetti I; Falcone A; Bertuccelli M; Cianci C; Ricci S; Conte PF
Am J Clin Oncol; 1994 Jun; 17(3):210-4. PubMed ID: 8192103
[TBL] [Abstract][Full Text] [Related]
20. 5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules.
John WJ; Neefe JR; Macdonald JS; Cantrell J; Smith M
Cancer; 1993 Dec; 72(11):3191-5. PubMed ID: 8242541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
